A fractional CMO in Massachusetts is a senior Chief Marketing Officer engaged on a part-time retainer basis, giving Boston-area biotech, life sciences, and technology companies, Cambridge research spinouts, and Massachusetts financial services and healthcare organizations C-suite marketing leadership without the cost of a full-time executive hire.
Serving Boston • Cambridge • Worcester • Somerville • Newton • Lowell • Quincy • Springfield and across Massachusetts
A fractional CMO is a part-time chief marketing officer who provides C-suite marketing leadership, demand generation strategy, and revenue accountability for growth-stage B2B companies -- typically at 30-60% of the cost of a full-time hire. Fractional CMO engagements run $8,000-$20,000/month with no long-term commitment, enabling companies at $1M-$30M revenue to access executive-level marketing expertise without a permanent C-suite hire.
Massachusetts has arguably the densest concentration of research-driven commercial activity in the United States. Kendall Square in Cambridge is the global center of biotech and life sciences, while the Route 128 corridor carries one of the largest clusters of technology and defense companies in the country. Boston's financial services sector manages trillions in assets. All three of these industry clusters produce companies that are scientifically or technically excellent but often underinvested in commercial marketing.
A fractional CMO in Massachusetts bridges that gap - translating complex life sciences or technology value propositions into clear commercial narratives, building the demand generation infrastructure that pre-commercial or early-commercial biotech companies need before a product launch, and developing the brand positioning that Boston fintech and financial services firms need to acquire institutional and retail clients at scale.
Engagements are designed to start quickly - typically within one to two weeks - and scale in scope as your commercial needs evolve through fundraising rounds, regulatory milestones, or market expansion phases.
Commercial marketing strategy for Massachusetts life sciences companies preparing for product launch, partnership development, or investor communications targeting strategic acquirers.
Full-funnel lead generation programs for Boston and Route 128 technology companies targeting enterprise buyers in healthcare, financial services, and defense verticals.
Differentiated positioning for Massachusetts companies competing in crowded markets - from Kendall Square biotech to Boston fintech to Worcester industrial technology firms.
Marketing-side support for Series A through C fundraising, partnership negotiations, and strategic communications aligned to your regulatory or commercial milestone timeline.
Channel strategy, pricing communication, and launch execution for Massachusetts companies entering new markets - commercial, international, or across new buyer segments.
Direct oversight of marketing staff and agency partners, with accountability to pipeline and commercial revenue outcomes rather than activity-based reporting.
See if Mark can actually help your growth.
Check if you're a fit →Free, no obligation. If it's a fit, you'll pick a time to talk with Mark directly.Remote-first with on-site availability across Massachusetts' major markets.
Transparent pricing with no long-term lock-in. Start in 1-2 weeks.
WETYR Corp provides M&A advisory services for Massachusetts companies preparing for acquisition, merger, or strategic partnership. In the Boston and Cambridge biotech ecosystem, marketing narrative quality can significantly affect valuation in acquisition discussions with large pharmaceutical and medical device acquirers.
Identify marketing gaps that reduce valuation before taking your Massachusetts business to market.
Build the marketing-to-revenue story that strategic acquirers and private equity buyers need documented.
Quantify brand equity as a measurable component of total enterprise value in Massachusetts transactions.
Prepare CIM supplements and marketing data rooms for clean due diligence in Massachusetts deals.
Marketing integration planning for Massachusetts companies acquired by pharma, private equity, or strategic buyers.
Translate commercial marketing performance into a compelling forward narrative for acquirer presentations.
Yes. Pre-commercial life sciences companies have significant marketing needs - building investor relations materials, developing key opinion leader relationships, establishing scientific credibility in commercial channels, and preparing the market for a product launch. A fractional CMO provides the strategic leadership to do this without hiring a permanent executive before commercial revenue justifies it.
Fractional CMO engagements in Massachusetts start at $8,000 for a sprint. Monthly retainers range from $8,000 to $20,000 based on scope, hours, and team leadership. Equity-blended structures are available for Cambridge and Boston startups at the Series A and B stage.
Most engagements launch within one to two weeks. A discovery call, a scope summary, and a retainer agreement are all that is required - no lengthy procurement processes or vendor credentialing.
Yes. Boston's financial services sector includes asset managers, insurance companies, fintech startups, and investment platforms that each need differentiated positioning and compliant marketing execution. A fractional CMO familiar with financial services regulatory constraints can build growth programs within those requirements.
The strongest fit is typically a company with $2M to $50M in revenue or a funded pre-revenue life sciences company. This includes Cambridge spinouts post-Series A, Boston SaaS companies at $5M-$20M ARR, and Route 128 technology firms expanding into enterprise sales motions.
30 minutes with Mark Gabrielli. No pitch — just a direct assessment of your biggest marketing gaps and what would move revenue the fastest. He answers personally.
Takes 60 seconds. Mark will personally follow up within 24 hours.
Mark will personally reach out within 24 hours. In the meantime, feel free to email him directly or call +1 (321) 917-5738.
See Mark's Methodology →